ConvaTec Group PLC (CNVVY)
13.02
+0.84
(+6.93%)
USD |
OTCM |
May 03, 15:45
ConvaTec Group Price to Book Value: 3.941 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 3.686 |
| May 01, 2024 | 3.769 |
| April 30, 2024 | 3.930 |
| April 29, 2024 | 3.823 |
| April 26, 2024 | 3.930 |
| April 25, 2024 | 4.117 |
| April 24, 2024 | 4.350 |
| April 23, 2024 | 4.325 |
| April 22, 2024 | 4.252 |
| April 19, 2024 | 4.302 |
| April 18, 2024 | 4.276 |
| April 17, 2024 | 4.261 |
| April 16, 2024 | 4.261 |
| April 15, 2024 | 4.299 |
| April 12, 2024 | 4.299 |
| April 11, 2024 | 4.341 |
| April 10, 2024 | 4.281 |
| April 09, 2024 | 4.269 |
| April 08, 2024 | 4.269 |
| April 05, 2024 | 4.400 |
| April 04, 2024 | 4.47 |
| April 03, 2024 | 4.568 |
| April 02, 2024 | 4.541 |
| April 01, 2024 | 4.472 |
| March 28, 2024 | 4.456 |
| Date | Value |
|---|---|
| March 27, 2024 | 4.456 |
| March 26, 2024 | 4.526 |
| March 25, 2024 | 4.411 |
| March 22, 2024 | 4.411 |
| March 21, 2024 | 4.480 |
| March 20, 2024 | 4.480 |
| March 19, 2024 | 4.480 |
| March 18, 2024 | 4.290 |
| March 15, 2024 | 4.290 |
| March 14, 2024 | 4.290 |
| March 13, 2024 | 4.290 |
| March 12, 2024 | 4.25 |
| March 11, 2024 | 4.25 |
| March 08, 2024 | 4.25 |
| March 07, 2024 | 4.25 |
| March 06, 2024 | 3.775 |
| March 05, 2024 | 3.775 |
| March 04, 2024 | 3.775 |
| March 01, 2024 | 3.775 |
| February 29, 2024 | 3.751 |
| February 28, 2024 | 3.751 |
| February 27, 2024 | 3.751 |
| February 26, 2024 | 3.751 |
| February 23, 2024 | 3.751 |
| February 22, 2024 | 3.751 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.121
Minimum
Jun 03 2019
4.568
Maximum
Apr 03 2024
3.323
Average
3.360
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.465 |
| Biodexa Pharmaceuticals Plc | 0.8756 |
| Verona Pharma PLC | 5.090 |
| NuCana PLC | 0.4460 |
| Autolus Therapeutics PLC | 9.984 |
Price to Book Value Related Metrics
| PE Ratio | 51.66 |
| PS Ratio | 3.118 |
| PEG Ratio | 5.992 |
| Price to Free Cash Flow | 28.04 |
| Price | 13.02 |
| Earnings Yield | 1.94% |
| Market Cap | 6.671B |
| PEGY Ratio | 4.854 |
| Operating PE Ratio | 25.19 |
| Normalized PE Ratio | 44.25 |